Relapsing-remitting multiple sclerosis and Narcolepsy

Summary:

Narcolepsy is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Narcolepsy with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 23 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Narcolepsy?

Narcolepsy (brain's inability to regulate sleep-wake cycles normally) is found to be associated with 422 drugs and 740 conditions by eHealthMe. Check the latest studies of Narcolepsy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 09, 2026

23 people who have Relapsing-Remitting Multiple Sclerosis and Narcolepsy are studied.

Would you have Narcolepsy when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Narcolepsy *:

female: 91.3 %
male: 8.7 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Narcolepsy *:

Common co-existing conditions for these people *:

Migraine (headache): 2 people, 8.70%
Depression: 2 people, 8.70%
Stress And Anxiety: 2 people, 8.70%
Pain: 2 people, 8.70%
Vulvovaginal Dryness: 1 person, 4.35%
Headache (pain in head): 1 person, 4.35%
High Blood Cholesterol: 1 person, 4.35%
Hypersensitivity: 1 person, 4.35%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 4.35%
Muscle Spasms (muscle contraction): 1 person, 4.35%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 9 people, 39.13%
Drowsiness: 8 people, 34.78%
Weight Increased: 7 people, 30.43%
Sleep Apnea Syndrome: 7 people, 30.43%
Nausea (feeling of having an urge to vomit): 7 people, 30.43%
Weakness: 6 people, 26.09%
Memory Loss: 6 people, 26.09%
Fall: 6 people, 26.09%
Insomnia (sleeplessness): 5 people, 21.74%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 5 people, 21.74%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Narcolepsy?

- Check whether Narcolepsy is associated with a drug or a condition

Related publications that referenced our studies

Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .

Related studies:

Treatments, associated drugs and conditions:

Relapsing-remitting multiple sclerosis (76,275 reports)
Narcolepsy (79,890 reports)

All the drugs that are associated with Narcolepsy:

Narcolepsy (422 drugs)

All the conditions that are associated with Narcolepsy:

Narcolepsy (740 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Narcolepsy and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.